Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Chai Discovery
Chai Discovery scores $70M for de novo antibody design
By
Anthony Vecchione
|
02:46 pm |
August 07, 2025
The company said it plans to develop its new Chai‑2 platform to design, from square one, completely new antibodies for viruses and cancer.